This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chatterji, U.
Right arrow Articles by Elder, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chatterji, U.
Right arrow Articles by Elder, J. H.

 Previous Article  |  Next Article 

Journal of Virology, March 2000, p. 2533-2540, Vol. 74, No. 6
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Feline Immunodeficiency Virus Vif Localizes to the Nucleus

Udayan Chatterji,1 Chris K. Grant,2 and John H. Elder1,*

Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037,1 and Custom Monoclonals International, West Sacramento, California 956912

Received 4 October 1999/Accepted 8 December 1999

Monoclonal antibodies prepared against recombinant Vif derived from the 34TF10 strain of feline immunodeficiency virus (FIV) were used to assess the expression and localization of Vif in virus-infected cells. Analyses by Western blotting and by immunoprecipitation from cells infected with FIV-34TF10 revealed the presence of a single 29-kDa species specific for virus-infected cells. Confirmation of antibody specificity was also performed by specific immunoprecipitation of in vitro-transcribed and -translated recombinant Vif. Localization experiments were also performed on virus-infected cells, using different fixation procedures. Results for methanol fixation protocols similar to those reported for localization of human immunodeficiency virus (HIV) Vif showed a predominant cytoplasmic localization for FIV Vif, very similar to localization of HIV type 1 Vif and virtually identical to the localization observed for the Gag antigens of the virus. However, with milder fixation procedures that used 2% formaldehyde at 4°C, FIV Vif was strongly evident in the nucleus. The localization was distinct from the nuclear localization noted with Rev and did not involve the nucleolus. Attempts to show colocalization or coprecipitation of Vif with Gag antigens were unsuccessful. In addition, Vif was not detected in purified FIV virions. The results are consistent with the notion that the primary role of Vif in virus infection initiates in the nucleus.


* Corresponding author. Mailing address: Department of Molecular Biology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 784-8270. Fax: (858) 784-2750. E-mail: jelder{at}scripps.edu.


Journal of Virology, March 2000, p. 2533-2540, Vol. 74, No. 6
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.-C., Marquet, R. (2009). Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol. Mol. Biol. Rev. 73: 211-232 [Abstract] [Full Text]  
  • Wichroski, M. J., Ichiyama, K., Rana, T. M. (2005). Analysis of HIV-1 Viral Infectivity Factor-mediated Proteasome-dependent Depletion of APOBEC3G: CORRELATING FUNCTION AND SUBCELLULAR LOCALIZATION. J. Biol. Chem. 280: 8387-8396 [Abstract] [Full Text]  
  • Ribeiro, A. C., Maia e Silva, A., Santa-Marta, M., Pombo, A., Moniz-Pereira, J., Goncalves, J., Barahona, I. (2005). Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3G. J. Virol. 79: 823-833 [Abstract] [Full Text]  
  • Feng, F., Davis, A., Lake, J.-A., Carr, J., Xia, W., Burrell, C., Li, P. (2004). Ring Finger Protein ZIN Interacts with Human Immunodeficiency Virus Type 1 Vif. J. Virol. 78: 10574-10581 [Abstract] [Full Text]  
  • Cen, S., Guo, F., Niu, M., Saadatmand, J., Deflassieux, J., Kleiman, L. (2004). The Interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem. 279: 33177-33184 [Abstract] [Full Text]  
  • Liu, B., Yu, X., Luo, K., Yu, Y., Yu, X.-F. (2004). Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G. J. Virol. 78: 2072-2081 [Abstract] [Full Text]  
  • Kao, S., Akari, H., Khan, M. A., Dettenhofer, M., Yu, X.-F., Strebel, K. (2002). Human Immunodeficiency Virus Type 1 Vif Is Efficiently Packaged into Virions during Productive but Not Chronic Infection. J. Virol. 77: 1131-1140 [Abstract] [Full Text]  
  • Madani, N., Millette, R., Platt, E. J., Marin, M., Kozak, S. L., Bloch, D. B., Kabat, D. (2002). Implication of the Lymphocyte-Specific Nuclear Body Protein Sp140 in an Innate Response to Human Immunodeficiency Virus Type 1. J. Virol. 76: 11133-11138 [Abstract] [Full Text]  
  • Chatterji, U., de Parseval, A., Elder, J. H. (2002). Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators. J. Virol. 76: 9624-9634 [Abstract] [Full Text]  
  • Henzler, T., Harmache, A., Herrmann, H., Spring, H., Suzan, M., Audoly, G., Panek, T., Bosch, V. (2001). Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure. J. Gen. Virol. 82: 561-573 [Abstract] [Full Text]  
  • Dettenhofer, M., Cen, S., Carlson, B. A., Kleiman, L., Yu, X.-F. (2000). Association of Human Immunodeficiency Virus Type 1 Vif with RNA and Its Role in Reverse Transcription. J. Virol. 74: 8938-8945 [Abstract] [Full Text]